Process View
The chemical reactions and pathways involving pigment, any general or particular coloring matter in living organisms, e.g. melanin.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "pigment metabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.526 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.269 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.266 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.177 | ||
| ARHGAP1 | Rho GTPase activating protein 1 | 0.159 | ||
| JUP | junction plakoglobin | 0.155 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.099 | Fly | |
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.091 | ||
| MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.090 | ||
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.090 | Fly | |
| EGFR | epidermal growth factor receptor | 0.071 | ||
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.069 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.063 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.062 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.059 | Human | |
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.056 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.055 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.054 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.049 | Fly | |
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.046 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.045 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.044 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.043 | ||
| BCL2L1 | BCL2-like 1 | 0.033 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.033 | ||
| MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.033 | ||
| JUN | jun proto-oncogene | 0.031 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.029 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.028 | ||
| ATP8 | ATP synthase F0 subunit 8 | 0.027 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.027 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.025 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.025 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.024 | Fly | |
| DSG2 | desmoglein 2 | 0.024 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.024 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.022 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.022 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.021 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.020 | ||
| BCR | breakpoint cluster region | 0.020 | ||
| EFNA1 | ephrin-A1 | 0.019 | ||
| ZNF746 | zinc finger protein 746 | 0.019 | ||
| WDYHV1 | WDYHV motif containing 1 | 0.018 | ||
| GARS | glycyl-tRNA synthetase | 0.018 | ||
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.018 | Fly | |
| MAPRE3 | microtubule-associated protein, RP/EB family, member 3 | 0.018 | Fly | |
| RHOA | ras homolog gene family, member A | 0.017 | Fly | |
| EFNA5 | ephrin-A5 | 0.017 | ||
| YARS | tyrosyl-tRNA synthetase | 0.016 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.015 | ||
| BBS1 | Bardet-Biedl syndrome 1 | 0.015 | ||
| ARRB1 | arrestin, beta 1 | 0.015 | ||
| PTN | pleiotrophin | 0.015 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.014 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.014 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.013 | ||
| MARS | methionyl-tRNA synthetase | 0.013 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.012 | Fly | |
| PCM1 | pericentriolar material 1 | 0.012 | ||
| BBS2 | Bardet-Biedl syndrome 2 | 0.012 | ||
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.012 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.012 | ||
| EEF2 | eukaryotic translation elongation factor 2 | 0.011 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.011 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.011 | Fly | |
| RAB27A | RAB27A, member RAS oncogene family | 0.011 | ||
| RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 0.011 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.011 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.011 | ||
| EXOC7 | exocyst complex component 7 | 0.010 | ||
| PCBD1 | pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha | 0.010 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.010 |